Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Aug 31, 2025 | (Q4)Aug 31, 2025 | (Q3)May 31, 2025 | (Q2)Feb 28, 2025 | (Q1)Nov 30, 2024 | (FY)Aug 31, 2024 | (Q4)Aug 31, 2024 | (Q3)May 31, 2024 | (Q2)Feb 29, 2024 | (Q1)Nov 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -252.76%-13.61M | -472.40%-4.24M | -205.80%-3.66M | -429.37%-4.42M | -18.98%-1.29M | -108.93%-3.86M | 9.10%-740.11K | -1.2M | -86.18%-834.71K | -85.76%-1.09M |
| Net income from continuing operations | -305.43%-16.49M | -1,705.08%-6.26M | -238.17%-5.42M | -141.51%-2.58M | -112.82%-2.24M | -124.92%-4.07M | 69.34%-346.7K | ---1.6M | -217.22%-1.07M | -208.00%-1.05M |
| Operating gains losses | 462.08%89.57K | --169.84K | ---53.54K | ---6.51K | ---20.22K | -0.61%-24.74K | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 335.55%86.58K | 509.88%38.23K | 3,501.14%22.08K | 19.42%15.52K | --10.76K | 8,696.02%19.88K | --6.27K | --613 | --13K | --0 |
| Asset impairment expenditure | --0 | ---- | ---- | --170.18K | --112.37K | ---63.95K | ---- | ---- | --0 | --0 |
| Remuneration paid in stock | 502.88%2.24M | 387.47%699.98K | 2,126.08%830.28K | 989.85%354.4K | 125.03%356.18K | 564.96%371.69K | 350.19%143.6K | --37.3K | 35.49%32.52K | --158.28K |
| Other non cashItems | -56.85%16.18K | ---- | ---- | ---- | ---- | --37.5K | --0 | --0 | ---613 | --38.11K |
| Change In working capital | 445.10%450.22K | 341.47%1.1M | 238.37%1.24M | -1,363.49%-2.37M | 311.16%486.7K | -87.86%-130.46K | -246.99%-454.58K | --366.66K | 239.21%187.96K | 5.42%-230.49K |
| -Change in receivables | -825.23%-189.55K | -52.45%38.2K | 245.90%146.56K | -1,877.66%-194.17K | -1,494.43%-180.14K | 3.60%-20.49K | 1,708.75%80.34K | ---100.45K | 228.58%10.92K | -45.56%-11.3K |
| -Change in prepaid assets | -1,186.96%-2.35M | -19.50%-217.8K | -108.15%-12.41K | -26,701.27%-2.14M | 116.55%26.53K | -275.82%-182.26K | -169.42%-182.26K | --152.24K | 122.72%8.05K | 41.84%-160.29K |
| -Change in payables and accrued expense | 4,029.84%2.99M | 462.19%1.28M | 251.42%1.11M | -122.92%-38.73K | 1,187.14%640.3K | 23,678.95%72.29K | -781.74%-352.66K | --314.87K | 285.54%168.98K | -248.55%-58.9K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -252.76%-13.61M | -472.40%-4.24M | -205.80%-3.66M | -429.37%-4.42M | -18.98%-1.29M | -108.93%-3.86M | 9.10%-740.11K | ---1.2M | -86.18%-834.71K | -85.76%-1.09M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -141.66%-381.37K | -28.96%-102.3K | -9.51K | -191.55%-228.84K | -40.73K | -328.52%-157.82K | -132.74%-79.32K | 0 | -134.70%-78.49K | 0 |
| Net PPE purchase and sale | -109.07%-329.94K | 35.88%-50.86K | ---9.51K | -191.55%-228.84K | ---40.73K | -328.52%-157.82K | -132.74%-79.32K | --0 | -134.70%-78.49K | --0 |
| Net investment purchase and sale | ---51.44K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -141.66%-381.37K | -28.96%-102.3K | ---9.51K | -191.55%-228.84K | ---40.73K | -328.52%-157.82K | -132.74%-79.32K | --0 | -134.70%-78.49K | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 577.18%42.1M | 1,049.11%23.31M | -95.72%96.56K | 1.43M | 792.42%17.26M | 490.65%6.22M | 470,650.12%2.03M | 2.25M | 0 | 404.43%1.93M |
| Net issuance payments of debt | ---44.39K | ---25.33K | ---- | ---- | --0 | --0 | --0 | ---- | ---- | --0 |
| Net common stock issuance | 639.10%39.86M | 1,794.37%22.82M | --0 | ---20.24K | 781.86%17.05M | 412.34%5.39M | 279,426.91%1.2M | --2.25M | --0 | 404.43%1.93M |
| Proceeds from stock option exercised by employees | 177.45%2.29M | -37.22%517.42K | --280.36K | --1.31M | --177.09K | --824.17K | --824.17K | --0 | ---- | ---- |
| Net other financing activities | ---- | ---- | ---- | --137.6K | --27.13K | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 577.18%42.1M | 1,049.11%23.31M | -95.72%96.56K | --1.43M | 792.42%17.26M | 490.65%6.22M | 470,650.12%2.03M | --2.25M | --0 | 404.43%1.93M |
| Net cash flow | ||||||||||
| Beginning cash position | 3,071.88%2.27M | 973.02%11.4M | 213,368.83%14.98M | 1,877.52%18.2M | 3,071.88%2.27M | -91.01%71.63K | 65.23%1.06M | -98.91%7.02K | 101.74%920.22K | -91.01%71.63K |
| Current changes in cash | 1,177.28%28.11M | 1,468.92%18.98M | -438.90%-3.58M | -252.43%-3.22M | 1,776.70%15.93M | 403.46%2.2M | 311.65%1.21M | --1.06M | -588.49%-913.2K | 349.14%848.59K |
| End cash Position | 1,237.01%30.38M | 1,237.01%30.38M | 973.02%11.4M | 213,368.83%14.98M | 1,877.52%18.2M | 3,071.88%2.27M | 3,071.88%2.27M | 65.23%1.06M | -98.91%7.02K | 101.74%920.22K |
| Free cash from | -247.11%-13.94M | -423.19%-4.29M | -206.59%-3.67M | -408.93%-4.65M | -22.73%-1.33M | -117.48%-4.02M | -41.73%-819.43K | ---1.2M | -89.55%-913.2K | -37.93%-1.09M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.